A carregar...
Combination Therapy with Topotecan, Paclitaxel, and Bevacizumab Improves Progression-Free Survival in Recurrent Small Cell Neuroendocrine Carcinoma of the Cervix
OBJECTIVES: To assess if the combination of topotecan, paclitaxel, and bevacizumab (TPB) was active in recurrent SCCC and to compare the survival of patients with SCCC who received TPB to a group of women with SCCC who did not receive this regimen. METHODS: We retrospectively analyzed women with rec...
Na minha lista:
| Publicado no: | Gynecol Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5873577/ https://ncbi.nlm.nih.gov/pubmed/27823771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2016.10.040 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|